{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:07:15Z","timestamp":1784876835676,"version":"3.55.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mco.2017.1372","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T06:37:17Z","timestamp":1502433437000},"page":"547-552","source":"Crossref","is-referenced-by-count":11,"title":["A retrospective study of late adverse events in proton beam therapy for prostate cancer"],"prefix":"10.3892","volume":"7","author":[{"given":"Hirokazu","family":"Makishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhito","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Fukumitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"key20180107151311_b1-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0360-3016(03)00665-5","article-title":"Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer","volume":"57","author":"Fiorino","year":"2003","journal-title":"Int J Radiat Oncol Biol Phy"},{"key":"key20180107151311_b2-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"key":"key20180107151311_b3-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2006.06.056","article-title":"Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer","volume":"66","author":"Ishikawa","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b4-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.ijrobp.2011.12.070","article-title":"Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406","volume":"83","author":"Michalski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b5-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2009.01.062","article-title":"Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I\/II dose escalation study","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b6-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b7-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","article-title":"High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): A randomised, controlled, phase 3 trial","volume":"16","author":"Zapatero","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20180107151311_b8-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1118\/1.597522","article-title":"The 200-MeV proton therapy project at the Paul Scherrer Institute: Conceptual design and practical realization","volume":"22","author":"Pedroni","year":"1995","journal-title":"Med Phys"},{"key":"key20180107151311_b9-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose, conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"key20180107151311_b10-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.50.6.349","article-title":"External beam radiation therapy for prostate cancer","volume":"50","author":"Horwitz","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"key20180107151311_b11-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b12-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijrobp.2005.12.017","article-title":"Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding","volume":"65","author":"Akimoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b13-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0360-3016(00)01496-6","article-title":"Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer","volume":"49","author":"Fenwick","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b14-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1088\/0031-9155\/50\/13\/008","article-title":"Dosimetric impact of image-guided 3D conformal radiation therapy of prostate cancer","volume":"50","author":"Schaly","year":"2005","journal-title":"Phys Med Biol"},{"key":"key20180107151311_b15-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","article-title":"Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer","volume":"84","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b16-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1007\/BF02446649","article-title":"Characteristics of proton beams after field shaping at PMRC","volume":"31","author":"Inada","year":"1993","journal-title":"Med Biol Eng Comput"},{"key":"key20180107151311_b17-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0360-3016(00)01414-0","article-title":"Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms","volume":"49","author":"Jackson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b18-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2010.09.058","article-title":"Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: An exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity","volume":"82","author":"Pederson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b19-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.10657","article-title":"Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era","volume":"95","author":"D'Amico","year":"2002","journal-title":"Cancer"},{"key":"key20180107151311_b20-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"key20180107151311_b21-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2007.01.043","article-title":"Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer","volume":"68","author":"Vora","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b22-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"},{"key":"key20180107151311_b23-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b24-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b25-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-717X-4-50","article-title":"Image guided dose escalated prostate radiotherapy: Still room to improve","volume":"4","author":"Martin","year":"2009","journal-title":"Radiat Oncol"},{"key":"key20180107151311_b26-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00066-013-0443-x","article-title":"Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcome using IMRT and volumetric IGRT","volume":"190","author":"Guckenberger","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"key20180107151311_b27-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00002302","article-title":"Value and perspectives of proton radiation therapy for limited stage prostate cancer","volume":"176","author":"Schulte","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"key20180107151311_b28-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2013.11.007","article-title":"Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer","volume":"88","author":"Mendenhall","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b29-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"E186","DOI":"10.1016\/j.ijrobp.2015.07.1025","article-title":"Long-term outcomes in patients treated with proton therapy for localized prostate cancer","volume":"93","author":"Takagi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b30-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2016.02.038","article-title":"Five-year biochemical results, toxicity and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b31-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijrobp.2004.12.017","article-title":"Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity","volume":"63","author":"Vargas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b32-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14338\/IJPT.13-00003.1","article-title":"Proton therapy vs. VMAT for prostate cancer: A treatment planning study","volume":"1","author":"Rana","year":"2014","journal-title":"International Journal of Particle Therapy"},{"key":"key20180107151311_b33-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jmrs.175","article-title":"Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles","volume":"64","author":"Rana","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"key20180107151311_b34-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.prro.2015.02.010","article-title":"Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy","volume":"5","author":"McDonald","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"key20180107151311_b35-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13014-016-0761-0","article-title":"Treatment planning comparison of IMPT, VMAT and 4\u03c0 radiotherapy for prostate cases","volume":"12","author":"Tran","year":"2017","journal-title":"Radiat Oncol"},{"key":"key20180107151311_b36-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2016.08.011","article-title":"Favorable preliminary outcomes for men with low- and intermediate-risk prostate cancer treated with 19-Gy single-fraction high-dose-rate brachytherapy","volume":"97","author":"Krauss","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107151311_b37-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/cncr.30050","article-title":"Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy","volume":"122","author":"Kasuya","year":"2016","journal-title":"Cancer"},{"key":"key20180107151311_b38-mco-0-0-1372","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:13:27Z","timestamp":1515338007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,11]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mco.2017.1372"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1372","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]}}}